National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

190

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C02AC05	CYNT	B	Moxonidine - 0.3mg	0.3mg	Tablet, film coated	1,266,372 L.L
G04BD06	MICTONORM	B	Propiverine HCl - 5mg	5mg	Tablet, coated	1,917,663 L.L
J01FA09	KLACID RM	B	Clarithromycin - 500mg	500mg	Tablet, modified release	1,173,175 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 24mg	24mg	Injectable solution prolonged release	8,524,771 L.L
R05CA12	PROSPAN COUGH LIQUID	B	Dried Ivy leaf extract - 35mg/5ml	35mg/5ml	Liquid	353,431 L.L
S01GX07	ALLERGODIL	B	Azelastine HCl - 0.5mg/ml	0.5mg/ml	Drops solution	709,549 L.L
A10BH01	JANUVIA	B	Sitagliptin - 100mg	100mg	Tablet, film coated	1,884,067 L.L
C02AC05	CYNT	B	Moxonidine - 0.4mg	0.4mg	Tablet, film coated	1,266,372 L.L
G04BD07	DETRUSITOL	B	Tolterodine (tartrate) - 2mg	2mg	Tablet, film coated	1,995,606 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 32mg	32mg	Injectable solution prolonged release	8,524,771 L.L
R05CA12	PROSPAN COUGH SYRUP	B	Dried Ivy leaf extract - 35mg/5ml	35mg/5ml	Solution	353,431 L.L
A06AX05	RESOLOR	B	Prucalopride succinate - 2mg	2mg	Tablet, film coated	5,251,736 L.L
B01AF01	XARELTO	B	Rivaroxaban - 10mg	10mg	Tablet, film coated	1,588,892 L.L
C02CA04	CARDULAR	B	Doxazosin (mesylate) - 4mg	4mg	Tablet	755,239 L.L
C09BB04	COVERAM	B	Perindopril arginine - 10mg, Amlodipine - 5mg		Tablet	1,116,733 L.L
J05AR03	TRUVADA	B	Emtricitabine - 200mg, Tenofovir disoproxil - 245mg		Tablet, film coated	21,319,383 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 64mg	64mg	Injectable solution prolonged release	34,835,645 L.L
D07AC13	ELOCOM	B	Mometasone furoate - 1mg/g	0.1%	Lotion	282,207 L.L
G04BD08	VESICARE	B	Solifenacin succinate - 5mg	5mg	Tablet, film coated	1,619,330 L.L
M05BA04	BINOSTO	B	Alendronate sodium - 70mg	70mg	Tablet, effervescent	1,709,368 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 96mg	96mg	Injectable solution prolonged release	34,835,645 L.L
S01GX09	PATANOL	B	Olopatadine (HCl) - 0.1%	0.1%	Drops solution	873,498 L.L
A06AX05	RESOLOR	B	Prucalopride succinate - 1mg	1mg	Tablet, film coated	3,273,600 L.L
M05BA06	BONVIVA	B	Ibandronic acid - 150mg	150mg	Tablet, film coated	1,265,900 L.L
N02BG06	ACUPAN	B	Nefopam HCl - 20mg	20mg	Injectable solution	365,525 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 128mg	128mg	Injectable solution prolonged release	34,835,645 L.L
C09BB04	COVERAM	B	Perindopril arginine - 10mg, Amlodipine - 10mg		Tablet	1,116,733 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 125mg/5ml, Clavulanic Acid (potassium) - 31.25mg/5ml	156.25mg/5ml	Powder for suspension	302,365 L.L
L01XX24	ONCASPAR	B	Pegaspargase - 750U/ml	750U/ml	Injectable powder for solution	172,758,585 L.L
A10BH02	GALVUS	B	Vildagliptin - 50mg	50mg	Tablet	950,097 L.L

...

190